Translumina launches VIVO ISAR, its Dual-Drug Polymer-free Coated Stent (DDCS) in International markets

Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company’s global growth journey  Translumina, a global developer and manufacturer of innovative cardiovascular medical devices used in interventional cardiology, announces the launch of VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in various International markets including Europe.  As an organization,…

thaipr.net

19 เม.ย. 65

Illumina Singapore Jumps the Ranks to Earn Two Significant Spots in Singapore’s Best Employers Award

The Annual Singapore’s Best Employers survey is sponsored by The Straits Times and marketing firm, Statista. Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) was honoured today to be ranked #17 overall and #1 in Healthcare Equipment & Services in Singapore’s Best Employers Award. The Singapore Employer of Choice is a large scale and comprehensive […]

thaipr.net

18 เม.ย. 65

TauRx’s late-stage clinical trial reaches new milestone

– Significant milestone in the only late-stage clinical trial targeting tau pathology of Alzheimer’s – TauRx on track to announce top line results in May – Trial aims to confirm efficacy of first tau-based treatment for Alzheimer’s TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer’s Disease (AD) research, has announced that the last patient has completed treatment […]

thaipr.net

18 เม.ย. 65

Esaote S.p.A. turns 40 and is confirmed as a leading player in the world market for diagnostic imaging with ultrasound systems, magnetic resonance imaging and information technology for healthcare

Esaote S.p.A., a leading biomedical company in the diagnostic imaging sector – in the fields of ultrasound, magnetic resonance and Information Technology for health – celebrates forty years of activity. Born from scratch in 1982, the Italian company – with headquarters in Genoa and present today in 100 countries around the world – has immediately carved […]

thaipr.net

18 เม.ย. 65

International Team Led by BGI Completes First Whole-Body Cell Atlas of a Non-Human Primate

The research will provide insights into the development of potential treatments for neurological diseases and obesity, among other human conditions. In a breakthrough that could lead to scientific advancement in the treatment of human diseases, researchers from BGI-Research, together with scientific research teams from China, Germany, Italy, Singapore, Spain, Sweden and the UK, today published […]

thaipr.net

18 เม.ย. 65

DEBIOPHARM ANNOUNCES ONCOLOGY RESEARCH ADVANCEMENTS AT AACR 2022 FOR NOVEL CANCER COMPOUNDS AND DRUG DELIVERY TECHNOLOGIES

Pre-clinical & clinical exploratory poster presentations to highlight oncology results withDebio 0123, xevinapant, and Multilink™ technology for antibody drug conjugates Debiopharm, (www.debiopharm.com/debiopharm-international/) an oncology and infectious disease focused biopharmaceutical company based in Switzerland, today announced data releases on 3 investigational products including Debio 0123 (Selective WEE1 inhibitor), clinical…

thaipr.net

12 เม.ย. 65

Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio’s preclinical advances in multiple therapeutic areas Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that it closed an oversubscribed fundraising round to support the next stage of […]

thaipr.net

12 เม.ย. 65

Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax’ COVID-19 Vaccine in Thailand

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world’s largest vaccine manufacturer by volume, today announced that the Thailand Food and Drug Administration (Thai FDA) has granted emergency use authorization (EUA) for Novavax’ protein-based vaccine for active immunization…

thaipr.net

11 เม.ย. 65
1 74 75 76 77 78 128